Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06441344
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-04
First Post:
2024-03-19
Brief Title:
Toripalimab Plus Anlotinib for the Maintenance of Extensive Stage Small Cell
Sponsor:
Taizhou Hospital
Organization:
Taizhou Hospital
Organization Data
Organization:
Taizhou Hospital
Class:
OTHER
Study ID:
SCLC-maintaine
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Taizhou Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Dongqing Lv MD
Responsible Party Title:
Chief medical officer
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Taizhou Hospital
Old Name:
None
Old Organization:
None